Munafa Stock Market Course + Intraday & FNO calls 
Supernus Pharmaceuticals (SUPN) Technical (Analysis) Reports Supernus Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Supernus Pharmaceuticals (SUPN)
Technical Analysis Report for USA stock SUPN Supernus Pharmaceuticals. Dated: 03 Mar 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock SUPN Supernus Pharmaceuticals then click here. or read Experts views on Supernus Pharmaceuticals or Forecast & share price targets of Supernus Pharmaceuticals
Supernus Pharmaceuticals Opened at 54.27 and Closed at: 54.56, which is -0.97% of previous session's close. It moved within a range of 52.95 and 55.00
The session was a Bullish session with an average volume of 720100, which is 34.16% of previous session's volumes.
- Even though the stock has fallen, but its short term trend is positive and in an uptrend.
- Even though the stock has fallen, but its mid term trend is positive and in an uptrend.
- Even though the stock has fallen, but its long term trend is positive and in an uptrend.
Support for tomorrow is 53.76 and resistance for tomorrow is 55.81
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 53.34, 52.12 resistance for tomorrow's hourly charts is 55.39, 56.22
10 Day SMA for Supernus Pharmaceuticals (SUPN) is 53.29 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Supernus Pharmaceuticals (SUPN) is 52 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Supernus Pharmaceuticals (SUPN) is 50.88 and the stock is trading above these levels. This is a good sign for its mid to long term trend
100 Day SMA is 49.58 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Supernus Pharmaceuticals is 44.01 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Supernus Pharmaceuticals is at 52 and 200 DMA is at 44.01, while 50 DMA and 100 DMA are at 50.88 and 49.58 respectively
Supernus Pharmaceuticals (SUPN) moving average of 20 SMA is at 52 and 20 EMA is at 52.48
| Date | Closing Price | 20 SMA | 20 EMA |
| 03 Tue Mar | 54.56 | 52 | 52.48 |
| 02 Mon Mar | 55.09 | 51.69 | 52.26 |
| 27 Fri Feb | 54.73 | 51.37 | 51.96 |
| 26 Thu Feb | 55.75 | 51.04 | 51.67 |
| 25 Wed Feb | 56.32 | 50.71 | 51.24 |
| 24 Tue Feb | 53.30 | 50.34 | 50.7 |
Supernus Pharmaceuticals (SUPN) moving average of 50 SMA is at 50.88 and 50 EMA is at 50.85
| Date | Closing Price | 50 SMA | 50 EMA |
| 03 Tue Mar | 54.56 | 50.88 | 50.85 |
| 02 Mon Mar | 55.09 | 50.77 | 50.7 |
| 27 Fri Feb | 54.73 | 50.65 | 50.52 |
| 26 Thu Feb | 55.75 | 50.52 | 50.35 |
| 25 Wed Feb | 56.32 | 50.35 | 50.13 |
| 24 Tue Feb | 53.30 | 50.17 | 49.88 |
Supernus Pharmaceuticals (SUPN) moving average of 100 SMA is at 49.58 and 100 EMA is at 48.92
| Date | Closing Price | 100 SMA | 100 EMA |
| 03 Tue Mar | 54.56 | 49.58 | 48.92 |
| 02 Mon Mar | 55.09 | 49.51 | 48.81 |
| 27 Fri Feb | 54.73 | 49.44 | 48.68 |
| 26 Thu Feb | 55.75 | 49.38 | 48.56 |
| 25 Wed Feb | 56.32 | 49.3 | 48.41 |
| 24 Tue Feb | 53.30 | 49.22 | 48.25 |
Supernus Pharmaceuticals (SUPN) moving average of 200 SMA is at 44.01 and 200 EMA is at 45.5
| Date | Closing Price | 200 SMA | 200 EMA |
| 03 Tue Mar | 54.56 | 44.01 | 45.5 |
| 02 Mon Mar | 55.09 | 43.89 | 45.41 |
| 27 Fri Feb | 54.73 | 43.78 | 45.31 |
| 26 Thu Feb | 55.75 | 43.67 | 45.21 |
| 25 Wed Feb | 56.32 | 43.55 | 45.1 |
| 24 Tue Feb | 53.30 | 43.42 | 44.99 |
Supernus Pharmaceuticals has performed better than Elanco Animal in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Encompass Health has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Encompass Health, about 1.74% more returns!
Supernus Pharmaceuticals has performed better than Abbott Laboratories in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Supernus Pharmaceuticals has performed better than Veru Inc in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Supernus Pharmaceuticals has performed better than Savara Inc in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Supernus Pharmaceuticals has performed better than Solid Biosciences in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Supernus Pharmaceuticals has performed better than Ultragenyx Pharmaceutical in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Supernus Pharmaceuticals has performed better than Quidel Corporation in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Supernus Pharmaceuticals has performed better than Proqr Therapeutics in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Supernus Pharmaceuticals has performed better than Mesoblast in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Jazz Pharmaceuticals has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Jazz Pharmaceuticals, about 1.47% more returns!
Supernus Pharmaceuticals has performed better than Ironwood Pharmaceuticals in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Supernus Pharmaceuticals has performed better than Iradimed Corporation in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Supernus Pharmaceuticals has performed better than Incyte Corporation in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Hoth Therapeutics has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Hoth Therapeutics, about 13.83% more returns!
Fate Therapeutics has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Fate Therapeutics, about 7.96% more returns!
Supernus Pharmaceuticals has performed better than Ascendis Pharma in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Supernus Pharmaceuticals has performed better than Alector Inc in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Supernus Pharmaceuticals has performed better than Aclaris Therapeutics in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Supernus Pharmaceuticals Technical analysis of indicators
Price action analysis of Supernus Pharmaceuticals (SUPN) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Supernus Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Supernus Pharmaceuticals in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Supernus Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Supernus Pharmaceuticals in short term but SELL signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Supernus Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 54.05 and Supernus Pharmaceuticals SUPN stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Supernus Pharmaceuticals SUPN stock. Volume based technical analysis of Supernus Pharmaceuticals SUPN stock is negative.
Supernus Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock SUPN Supernus Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And SUPN Experts View which covers a lot of information including buying and selling signals
SUPN future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Supernus Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Supernus Pharmaceuticals (SUPN) Technical (Analysis) Reports Supernus Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
